Literature DB >> 3011402

Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.

S H Cheng, W Markland, A F Markham, A E Smith.   

Abstract

The transforming activity of polyoma virus middle-T antigen is believed to be dependent on its ability to form a complex with the cellular tyrosine protein kinase, pp60c-src. This hypothesis is based on observations of mutants of middle-T which demonstrated a correlation between these two activities. To investigate further the significance of pp60c-src association in transformation by middle-T, a series of deletion and point mutants were constructed around the NG59 lesion since this region has been implicated in pp60c-src binding. Analysis of the middle-T variants revealed a complete correlation between the presence of associated activated pp60c-src and the ability to transform. Further, this ability of pp60c-src to associate with middle-T may depend on the presence of a beta-turn between amino acids 177 and 180. The results indicate the NG59 phenotype results from the introduction of an isoleucine residue between amino acids 177 and 178 rather than the transition mutation at 179. The mutant MG1 is a single point mutation (at residue 180) and represents the smallest change in the middle-T which abolishes both the transformating and kinase activity of middle-T. Taken together, the data suggest the region surrounding the NG59 lesion is involved in the formation of an active complex between middle-T and pp60c-src and strongly suggest that this association is an absolute requirement for polyoma virus-induced transformation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011402      PMCID: PMC1166736          DOI: 10.1002/j.1460-2075.1986.tb04216.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

Authors:  I MACPHERSON; L MONTAGNIER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts.

Authors:  L Raptis; H Lamfrom; T L Benjamin
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  In vitro mutagenesis of a putative DNA binding domain of SV40 large-T.

Authors:  D Kalderon; A E Smith
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

4.  N-terminal amino acid sequences of the polyoma middle-size T antigen are important for protein kinase activity and cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

5.  Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.

Authors:  J B Bolen; M A Israel
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

7.  Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen.

Authors:  W Yonemoto; M Jarvis-Morar; J S Brugge; J B Bolen; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  A new member of the polyomavirus family: the hamster papovavirus. Complete nucleotide sequence and transformation properties.

Authors:  V Delmas; C Bastien; S Scherneck; J Feunteun
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

9.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

10.  The complex of polyoma virus middle-T antigen and pp60c-src.

Authors:  S A Courtneidge; A E Smith
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  24 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.

Authors:  S H Cheng; P C Espino; J Marshall; R Harvey; A E Smith
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Cellular ras gene activity is required for full neoplastic transformation by polyomavirus.

Authors:  L Raptis; R Marcellus; M J Corbley; A Krook; J Whitfield; S K Anderson; T Haliotis
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

Review 5.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro.

Authors:  W C Morgan; D R Kaplan; D C Pallas; T M Roberts
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.

Authors:  W Markland; B A Oostra; R Harvey; A F Markham; W H Colledge; A E Smith
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

9.  In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.

Authors:  W Markland; S H Cheng; B A Oostra; A E Smith
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

10.  Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells.

Authors:  J B Bolen; V DeSeau; J O'Shaughnessy; S Amini
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.